IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
1.280
-0.020 (-1.54%)
At close: Feb 2, 2026, 4:00 PM EST
1.290
+0.010 (0.78%)
After-hours: Feb 2, 2026, 6:20 PM EST
IM Cannabis Revenue
IM Cannabis had revenue of 13.85M CAD in the quarter ending September 30, 2025, a decrease of -0.23%. This brings the company's revenue in the last twelve months to 52.38M, up 1.92% year-over-year. In the year 2024, IM Cannabis had annual revenue of 54.03M with 10.71% growth.
Revenue (ttm)
52.38M CAD
Revenue Growth
+1.92%
P/S Ratio
0.12
Revenue / Employee
551,389 CAD
Employees
95
Market Cap
6.72M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 54.03M | 5.23M | 10.71% |
| Dec 31, 2023 | 48.80M | -5.53M | -10.18% |
| Dec 31, 2022 | 54.34M | 20.28M | 59.56% |
| Dec 31, 2021 | 34.05M | 18.16M | 114.30% |
| Dec 31, 2020 | 15.89M | 6.82M | 75.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sunshine Biopharma | 37.32M |
| Biofrontera | 37.16M |
| cbdMD | 19.19M |
| Sonoma Pharmaceuticals | 16.94M |
| RedHill Biopharma | 9.55M |
| InMed Pharmaceuticals | 4.80M |
| China Pharma Holdings | 4.05M |
| China SXT Pharmaceuticals | 1.54M |
IMCC News
- 7 days ago - IM Cannabis Raises US$2,171,660.40 in Note Purchase Agreements - PRNewsWire
- 4 weeks ago - IM Cannabis Announces the Appointment of Mr. Alon Dayan to its Board of Directors - PRNewsWire
- 4 weeks ago - IM Cannabis Explores U.S. Market Entry Following President Trump's Executive Order on Increasing Medical Marijuana and Cannabidiol Research - PRNewsWire
- 7 weeks ago - IM Cannabis Appoints Asi Levi as Chief Financial Officer - PRNewsWire
- 2 months ago - IM Cannabis Reports Third Quarter 2025 Financial Results - PRNewsWire
- 3 months ago - IM Cannabis to Report third Quarter 2025 Financial Results on Thursday, November 13th at 9:00am ET - PRNewsWire
- 3 months ago - IM Cannabis Announces CFO Departure - PRNewsWire
- 3 months ago - Cannabis Investing 2025: 3 Pot Stocks to Watch Before November - MarijuanaStocks